Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A pilot phase 1 study of SequestOx (Immediate release Oxycodone Hydrochloride) compared to the reference drug, Roxicodone, to treat healthy male and female volunteers moderate to severe acute pain in the fed state

Next Previous
X
Search
Trial Profile

A pilot phase 1 study of SequestOx (Immediate release Oxycodone Hydrochloride) compared to the reference drug, Roxicodone, to treat healthy male and female volunteers moderate to severe acute pain in the fed state

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 05 Feb 2018

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Oxycodone/naltrexone (Primary) ; Oxycodone
  • Indications Pain
  • Focus Pharmacokinetics

    • Most Recent Events

    • 05 Feb 2018 New trial record
    • 30 Jan 2018 According to a Elite Pharmaceuticals media release, company is reviewing with FDA these results of the study for re-submission of the NDA.
    • 30 Jan 2018 Results published in the Elite Pharmaceuticals Media Release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top